Kevin Garey
Kevin Garey
Verified email at
Cited by
Cited by
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society …
LC McDonald, DN Gerding, S Johnson, JS Bakken, KC Carroll, SE Coffin, ...
Clinical infectious diseases 66 (7), e1-e48, 2018
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study
KW Garey, M Rege, MP Pai, DE Mingo, KJ Suda, RS Turpin, DT Bearden
Clinical infectious diseases 43 (1), 25-31, 2006
Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on …
S Johnson, V Lavergne, AM Skinner, AJ Gonzales-Luna, KW Garey, ...
Clinical infectious diseases 73 (5), e1029-e1044, 2021
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
KW Garey, S Sethi, Y Yadav, HL DuPont
Journal of Hospital infection 70 (4), 298-304, 2008
Collection and analysis of exhaled breath condensate in humans
GM Mutlu, KW Garey, RA Robbins, LH Danziger, I Rubinstein
American journal of respiratory and critical care medicine 164 (5), 731-737, 2001
T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial
E Mylonakis, CJ Clancy, L Ostrosky-Zeichner, KW Garey, GJ Alangaden, ...
Clinical Infectious Diseases 60 (6), 892-899, 2015
Economic healthcare costs of Clostridium difficile infection: a systematic review
SS Ghantoji, K Sail, DR Lairson, HL DuPont, KW Garey
Journal of Hospital Infection 74 (4), 309-318, 2010
Markers of inflammation in exhaled breath condensate of young healthy smokers
KW Garey, MM Neuhauser, RA Robbins, LH Danziger, I Rubinstein
Chest 125 (1), 22-26, 2004
Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
VH Tam, KT Chang, K Abdelraouf, CG Brioso, M Ameka, LA McCaskey, ...
Antimicrobial agents and chemotherapy 54 (3), 1160-1164, 2010
Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
VH Tam, CA Rogers, KT Chang, JS Weston, JP Caeiro, KW Garey
Antimicrobial agents and chemotherapy 54 (9), 3717-3722, 2010
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
KW Garey, SS Ghantoji, DN Shah, M Habib, V Arora, ZD Jiang, ...
Journal of antimicrobial chemotherapy 66 (12), 2850-2855, 2011
Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia
MP Pai, RS Turpin, KW Garey
Antimicrobial agents and chemotherapy 51 (1), 35-39, 2007
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
ND Beyda, J John, A Kilic, MJ Alam, TM Lasco, KW Garey
Clinical infectious diseases 59 (6), 819-825, 2014
Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways
MA Engevik, B Luk, AL Chang-Graham, A Hall, B Herrmann, W Ruan, ...
MBio 10 (3), 10.1128/mbio. 01087-19, 2019
Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the …
GV Doern, KC Carroll, DJ Diekema, KW Garey, ME Rupp, MP Weinstein, ...
Clinical microbiology reviews 33 (1), 10.1128/cmr. 00009-19, 2019
Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections
KW Garey, T Dao, H Chen, P Amrutkar, N Kumar, M Reiter, LO Gentry
Journal of Antimicrobial Chemotherapy 58 (3), 645-650, 2006
Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel
CJ Clancy, PG Pappas, J Vazquez, MA Judson, DP Kontoyiannis, ...
Clinical Infectious Diseases 66 (11), 1678-1686, 2018
Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections
L Gerard, KW Garey, HL DuPont
Expert review of anti-infective therapy 3 (2), 201-211, 2005
Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
ND Beyda, RE Lewis, KW Garey
Annals of Pharmacotherapy 46 (7-8), 1086-1096, 2012
Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the …
VH Tam, EA Gamez, JS Weston, LN Gerard, MT LaRocco, JP Caeiro, ...
Clinical infectious diseases 46 (6), 862-867, 2008
The system can't perform the operation now. Try again later.
Articles 1–20